Patient safety is one of healthcare’s most fundamental responsibilities. However despite continued advances in clinical guidelines, reporting systems, and safety protocols, patients remain exposed to preventable risks such as medication errors, missed clinical deterioration, hospital-acquired complications, falls, and other adverse events.

Artificial intelligence is emerging as an additional layer of protection. By analyzing large volumes of clinical information, detecting patterns associated with patient risk, and delivering timely decision support, AI can help healthcare professionals identify potential safety problems before they result in harm.

The opportunity extends beyond any single clinical task. AI systems are being evaluated for medication review, adverse-event detection, fall-risk prediction, pressure-injury prevention, incident classification, and other areas of clinical risk management. The evidence is increasingly promising, but its practical value depends on careful validation, workflow integration, and continued human oversight.

Key Findings

What the patient safety evidence shows

74%

High-risk prescriptions requiring pharmacist intervention identified by AI

Up to 98%

Accuracy reported in selected AI models for fall-risk prediction

Earlier detection

Adverse events and safety risks identified beyond conventional reporting systems

AI as a Clinical Safety Net

One of the clearest examples of AI supporting patient safety comes from medication management. Prescribing errors can arise from incorrect doses, drug interactions, contraindications, impaired renal function, polypharmacy, and other factors that may be difficult to evaluate consistently across thousands of medication orders.

A study published in the Journal of the American Medical Informatics Association evaluated a hybrid clinical decision-support system combining machine learning with rule-based alerts. The model was developed using data from 10,716 patients and 133,179 prescription orders, then tested on an independent validation dataset involving 412 patients and 3,364 prescription orders1.

The system identified 74% of prescription orders that required pharmacist intervention, while also achieving 74% precision. Its AUROC reached 0.81, compared with 0.65 for the hospital’s conventional clinical decision-support alerts and 0.68 for a multicriteria prioritization method1.

Importantly, none of the prescription errors missed by the model were classified as life-threatening. The study also found that the system reduced false alerts and improved the efficiency of medication review, helping pharmacists prioritize patients whose prescriptions were more likely to contain clinically relevant problems.

Beyond Medication Safety

Medication review is only one part of the patient safety landscape. A systematic review published in Frontiers in Medicine examined 52 publications covering both proactive and reactive applications of AI in clinical risk management2.

The review found that AI systems are being used to detect adverse events, predict medication errors, assess fall risk, identify pressure-injury risk, classify safety incidents, and uncover events that may not have been reported through conventional systems.

In fall-risk and pressure-injury prediction, selected machine-learning models achieved high discriminatory performance. Some models reached prediction accuracy of 98%, while another model for hospital-acquired and non-hospital-acquired pressure injuries achieved AUC values of 0.92 and 0.94 in separate test sets2.

Natural language processing also creates opportunities to improve safety surveillance. Rather than depending entirely on voluntary incident reports, AI can review clinical notes and event documentation to identify potential adverse events, classify their severity, and help safety teams prioritize cases requiring investigation.

Evidence Summary

AI can support safety across multiple clinical workflows

The strongest applications combine earlier risk identification with timely clinical review and targeted intervention.

Safety domain AI contribution
Medication errors High-risk medication orders are prioritized
Fall risk Patients at high risk are identified
Pressure injuries Earlier prevention is supported
Adverse-event detection Unreported events are detected
Real-world implementation Evidence remains limited

Performance reported in individual studies should not be interpreted as guaranteed effectiveness across every hospital, population, or clinical workflow.

From Risk Prediction to Harm Prevention

High predictive accuracy does not automatically translate into safer care. A system may correctly identify patients at risk, but its clinical impact depends on whether the result reaches the appropriate professional, at the right moment, in a format that supports action.

The value of AI therefore lies not only in prediction, but in the complete safety workflow that follows. Healthcare organizations must define who receives the alert, how quickly it must be reviewed, what action should follow, and how the outcome will be documented and monitored.

This is particularly important because poorly designed systems can introduce new risks. Excessive alerts may contribute to alert fatigue, inaccurate models may produce false reassurance, and systems that do not fit existing workflows may be ignored or bypassed.

Implementing AI for Safer Care

Safe implementation should begin with a clearly defined risk rather than a general desire to adopt AI. Organizations should identify the adverse event they want to prevent, establish the current baseline, and determine where existing safety processes fail to detect or manage that risk.

The system should then be validated using representative local data and tested through a controlled pilot. End users, including physicians, nurses, pharmacists, and safety teams, should be involved early so that alerts, interfaces, thresholds, and escalation pathways reflect real operational needs.

Once deployed, the technology requires continuous monitoring, periodic audits, user feedback, error analysis, and integration with existing electronic health records and reporting systems. Staff must also understand what the system can detect, where it may fail, and when clinical judgment should override its recommendations.

Conclusion

AI is becoming an increasingly important tool for identifying clinical risk before it results in patient harm. Evidence from medication review, adverse-event detection, falls, pressure injuries, and incident reporting demonstrates its potential to strengthen existing safety systems.

However, AI is not an independent guarantee of safety. Its impact depends on local validation, thoughtful workflow design, appropriate clinical oversight, effective training, and continuous monitoring. The most valuable systems do not replace healthcare professionals, they help them recognize risk earlier and intervene more effectively.

At Argenticare, we help healthcare organizations design and implement practical data and AI solutions that deliver measurable clinical and operational value. From strengthening patient safety and diagnostic accuracy to automating workflows and accelerating AI adoption, we combine medical and technical expertise to turn promising ideas into safe, effective solutions.

Ready to Explore AI for Your Organization?

Explore how Argenticare can support your goals with AI, data, and automation.

Explore Our Services Schedule a Call

References

  1. Corny J, Rajkumar A, Martin O, Dode X, Lajonchère JP, Billuart O, Bézie Y, Buronfosse A. A Machine Learning–Based Clinical Decision Support System to Identify Prescriptions With a High Risk of Medication Error. Journal of the American Medical Informatics Association. 2020;27(11):1688–1694.
  2. De Micco F, Di Palma G, Ferorelli D, De Benedictis A, Tomassini L, Tambone V, Cingolani M, Scendoni R. Artificial Intelligence in Healthcare: Transforming Patient Safety With Intelligent Systems: A Systematic Review. Frontiers in Medicine. 2025;11:1522554.